Patrick Kemmeren

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors.

Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors.

Journal: JCO precision oncology

Published: May 18, 2026

Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology.

Analytical Validation of an Annotation Tool for WGS-Based Pharmacogenomics: Preparing for Clinical Implementation in Pediatric Oncology.

Journal: Clinical and translational science

Published: October 31, 2025

A pathway-informed mutual exclusivity framework to detect genetic interactions in pediatric cancer.

A pathway-informed mutual exclusivity framework to detect genetic interactions in pediatric cancer.

Journal: BMC medical genomics

Published: July 14, 2025

Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].

Corrigendum to "Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program 'iTHER'" [Eur J Cancer 175 (2022) 311-325].

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 13, 2025

Implementing Pre-Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects.

Implementing Pre-Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects.

Journal: Clinical pharmacology and therapeutics

Published: January 06, 2025

M&M: an RNA-seq based pan-cancer classifier for paediatric tumours.

M&M: an RNA-seq based pan-cancer classifier for paediatric tumours.

Journal: EBioMedicine

Published: August 30, 2024

Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors.

Complex structural variation is prevalent and highly pathogenic in pediatric solid tumors.

Journal: Cell genomics

Published: December 18, 2023

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 15, 2023

Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.

Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.

Journal: Cell reports

Published: October 25, 2022

Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors.

Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors.

Journal: Cancers

Published: August 25, 2022

Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.

Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 18, 2022

Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.

Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS.

Journal: BMC cancer

Published: June 13, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026